Twelve stainless fermentation tanks of 25,000 litres each, plus their seed trains, changed hands in September 2026 for $75,000. That is 300,000 litres of installed capacity at $0.25 a litre, or $6,250 a tank. The seller’s plant was one of the largest dedicated biomass-fermentation sites in North America. The buyers are not making meat alternatives. They are growing plant cells.
The price is the headline. It is also the least useful number in the story for an operator, because it is the price of a distressed lot that emerged from a tax seizure, and because almost everything that makes a tank a working asset is missing from it. This piece sets out what was sold, what the reports agree on, where they disagree, and what a formulator, scale-up lead or investor should and should not take from a quarter-dollar-a-litre data point.
What was sold, and to whom
Four outlets report the deal in near-identical terms. Ayana Bio, a Boston-based plant-cell-culture company, and Zenfold Sustainable Technologies, an Indian specialty-chemicals manufacturer, jointly bought twelve 25,000-litre stainless-steel fermentation tanks and associated seed-culture equipment from the former Meati Foods site in Thornton, Colorado. The tanks are to be moved to Zenfold’s facilities in India, with operation targeted for the first half of 2027. AgFunderNews’s exclusive gives Bengaluru and Hyderabad as the candidate locations, and Green Queen and vegconomist carry the same core facts.
What the buyers will do with them matters more than where. Ayana Bio grows plant cells in bioreactors to make high-value compounds: rosmarinic acid from sage cells, crocins from saffron, and zeaxanthin and lutein from marigold. Zenfold already operates four 100,000-litre vessels in India. On that footing the Meati tanks are a middle rung: larger than pilot equipment, smaller than Zenfold’s production vessels, and useful for validating a cell line before committing it to 100,000 litres. Ayana Bio’s chief executive, Frank Jaksch, is quoted as saying the equipment would “expand our own dedicated pilot capabilities to perform consistent and cost-effective pilot-scale development on plant cell lines.”
| Item | Reported figure | Source |
|---|---|---|
| Tanks | 12 × 25,000 litres, stainless steel | AgFunderNews, Green Queen, MycoStories |
| Total volume | 300,000 litres | All outlets |
| Price | $75,000 | All outlets |
| Price per litre | $0.25 (our arithmetic: $75,000 ÷ 300,000) | Derived |
| Price per tank | $6,250 (our arithmetic) | Derived |
| Buyer’s existing capacity (Zenfold) | 4 × 100,000 litres | Green Queen, vegconomist |
| Target start-up | First half of 2027 | AgFunderNews, vegconomist |
Practical consequence: the per-litre figure is our arithmetic, not a reported price. None of the outlets we read states a per-litre price, and the deal was reported as a lot, not a rate.
Cost versus worth: two figures from the same executive
The buyer’s public account of the tanks’ original value comes in two different measures. AgFunderNews reports Ayana Bio chief executive Frank Jaksch saying the tanks and seed trains were “worth several million”. Green Queen quotes him on what Meati paid for them: “We estimate that they spent $15-20M for the fermentation equipment.”
Those are not contradictory: one is an estimate of cost, the other of value at the time of sale. But they give very different discount rates. Against “several million”, $75,000 is a steep discount. Against a $15 to $20 million spend, it is under 0.5% of cost. Both are the buyer’s own estimates, made by a party that benefits from the deal looking like a bargain, and neither is a documented invoice. We have not seen Meati’s fixed-asset records or the CRB construction contract values, and the outlets report the estimate without a source beyond Jaksch.
Green Queen also says Meati had raised $450 million to date, including a $150 million Series C in 2022 that valued it at $650 million. The company’s own January 2023 release said it had raised “more than $250 million to date.” The two are not necessarily in conflict, since money could have been raised after the release, but we have not reconciled them and neither figure is needed to size the tanks.
How a plant built to scale ended up as a $75,000 lot
The sequence, as reported by AgFunderNews and Green Queen, runs like this. Meati opened its “Mega Ranch” in Thornton in January 2023, describing a vertically integrated site that would grow, harvest, process and package on one footprint. The build engineer, CRB, describes a facility of more than 100,000 square feet, with groundbreaking in mid-2021 and first product completion in the fourth quarter of 2022.
In February 2025 the company breached financial covenants and its lender, Trinity Capital, swept two-thirds of its available cash, according to AgFunderNews’s property-seizure report of 6 January 2026. Meati’s parent, Emergy Inc., entered an assignment for the benefit of creditors in May 2025, with around 150 employees let go. Meati Holdings, led by entrepreneur Yasir Abdul, acquired the assets on 30 October 2025, per Cell-Ag. We covered that restructuring as one of the peer transactions in our analysis of who is actually acquiring alt-protein assets.
The revival did not hold. A writ of restitution was issued to the landlord on 8 December 2025, and on 23 December a distraint warrant was issued over goods, chattels and equipment at the fermentation facility for $6,686,757.50 in unpaid property taxes and interest, AgFunderNews reports. The property owner is named as 25 North Investors SPE1 LLC. The same report says that after $3.1 million in claims were filed in the creditor process, unsecured creditors received $10,000.
AgFunderNews reports that an online auction was scheduled for spring 2026 to sell the physical assets. Jaksch says Ayana Bio became aware of the equipment the previous December but “couldn’t figure out a way to make it work”, and that “In July 2026, we became aware that most of it was still available.” The deal reached print in mid-September.
Practical consequence: the $75,000 is the clearing price for what was still available after a tax seizure and a scheduled auction. It is a floor for a specific distressed lot. It is not a market price for used fermentation capacity.
What the $0.25 a litre leaves out
Tanks are not capacity. A working fermentation line is tanks plus sterile utilities, clean-in-place systems, air handling, heat removal, downstream separation and drying, controls, and the people and validation that make the whole thing run reproducibly. The reports describe the lot as tanks and seed trains. They do not say it includes downstream equipment, and they do not give any cost for the following:
- Decommissioning and removal from Colorado.
- Shipping and import into India.
- Reinstallation, utilities and commissioning at a Zenfold site.
- Validation for plant-cell processes, which differ from the mycelial biomass the tanks were built for.
Jaksch calls the opportunity “a game changer” for Ayana Bio’s pilot-scale development, and for a pilot-scale plant-cell programme it plausibly is. But the buyers are unusually well placed to absorb the unpriced items. Zenfold already runs four 100,000-litre vessels, so it has utilities, operators and quality systems to plug new tanks into. A buyer without an existing plant would face the whole list.
There is also a fit question the reports do not address. The tanks were installed to grow filamentous fungi for a meat analogue. Plant cells in suspension have different oxygen-transfer, shear and cycle-time demands. The move suggests the stainless volume is what the buyers valued; whether agitation, aeration and vessel design suit plant cells is not covered in anything we found.
For comparison of new-build economics, see our piece on MAASH, where a fresh financing funds a 12 m³ demonstrator on a site that once carried a far larger plant. The bases are not comparable: MAASH’s round funds more than tanks, and the Meati price excludes installation. The point is only that the same industry has both a €12 million-scale price for a small demonstrator and a $75,000 price for 300,000 litres of second-hand vessels, and no public series explains the gap between them.
The counter-argument
The case against reading much into this deal is straightforward. One transaction is one data point, struck between two parties who had a use for the tanks. We have no evidence either way on competing bidders. The seller’s position looks weak: the site was under a tax seizure and an auction had already been scheduled for the assets. A price set under those conditions says little about what a healthy operator would pay a healthy seller for a comparable vessel.
The other side of the argument is that failed alt-protein plants are not rare, and distressed stainless is going to keep appearing. The Believer Meats plant auction drew no qualifying bids. The BMC Ingredients case shows the opposite pressure, a plant that is full and turning orders away. Both facts can be true at once: capacity is short where it is fit for purpose and in the right place, and stranded where it was built around a single product that failed. Cell-Ag frames the Meati sale as “a price on stranded fermentation capacity.” Planet Food argues it marks a shift towards reusing infrastructure as platforms for multiple ingredients. Both are interpretations of a single sale, not findings.
Practical consequence: an operator sizing a capex plan should not benchmark against $0.25 a litre. An operator scouting for pilot capacity should treat failed-plant equipment as an option worth a phone call, with installation, validation and vessel-fit costs as the real budget lines.
What we could not establish
- The seller. The reports describe the equipment as coming from Meati Foods’ Thornton site. They do not say which legal entity sold it, and it may have been Meati Holdings, an assignee, or another party. We have not confirmed it.
- The original cost of the tanks. $15 to $20 million is Jaksch’s estimate of what Meati spent, and “worth several million” is his statement of value. We have seen no invoice or asset register.
- Working volume. Whether 25,000 litres is nominal or working volume is not stated.
- What is included. Downstream equipment, instrumentation and spares are not itemised in any report we read.
- Costs beyond the price. Removal, shipping, import duty, reinstallation and validation costs are not disclosed.
- How much of the lot was sold. Jaksch says “most of it” was still available in July 2026. Whether every tank and seed train in the original inventory is included is not stated, and we have not established the auction’s outcome beyond that.
- Vessel suitability for plant cells. Nothing we read addresses whether the tanks’ design suits plant-cell suspension culture.
- Meati’s total funding. $250 million-plus (company, January 2023) and $450 million (Green Queen) are both reported; we have not reconciled them.
What to watch
- Whether the tanks are commissioned at Zenfold in the first half of 2027, as targeted.
- Whether Ayana Bio or Zenfold disclose the all-in cost including removal and reinstallation. That would turn a distressed-lot price into a usable secondary-market benchmark.
- Whether other idle biomass-fermentation plants list equipment through auction or private sale, and at what prices. A second and third transaction would make a series; one is an anecdote.
- Whether the Thornton site itself finds a new tenant. Nothing we read says it has.